Literature DB >> 20007287

Positron emission tomography/computed tomography: a clinical tool for evaluation of enthesitis in patients with spondyloarthritides.

Yoshinori Taniguchi1, Kaoru Arii, Yoshitaka Kumon, Mitsutaka Fukumoto, Takenao Ohnishi, Taro Horino, Toru Kagawa, Shigeto Kobayashi, Yasuhiro Ogawa, Yoshio Terada.   

Abstract

OBJECTIVE: To evaluate the accuracy of PET/CT using [(18)F]fluorodeoxyglucose (FDG) in determining the presence of enthesitis in patients with SpAs.
METHODS: Results of PET/CT scans of eight patients with SpA and seven patients with RA were retrospectively examined, with specific focus on five joints and three entheses. Volume fixation values are expressed as standardized uptake values (SUVs). Data from 20 patients with non-rheumatic (NR) diseases and 20 healthy subjects were also examined if non-specific, false positive findings were possible. We evaluated the clinical utility of PET/CT examinations in SpA, compared with MRI and Ga scintigraphy.
RESULTS: Images of PET/CT scans of the shoulder, hip and knee joints revealed that FDG accumulated at the entheses in SpA and in the synovium in RA patients. The maximum SUVs [mean (s.d.)] were statistically higher in SpA patients compared with RA patients at the entheses of lumbar spinous process [4.83 (1.15) vs 1.42 (0.34); P < 0.05, respectively], pubic symphysis [3.93 (0.87) vs 1.35 (0.31); P < 0.05, respectively] and ischial tuberosity [4.76 (1.5) vs 1.35 (0.42); P < 0.05, respectively]. The positive frequencies of lumbar spinous processes and ischial tuberosity evaluated by PET/CT scan in the SpA group were significantly higher than that evaluated by MRI.
CONCLUSION: MRI is now widely used to detect bone marrow oedema and enthesitis in patients with SpA. PET/CT scans offer an alternative method to identify enthesitis, and will likely contribute to the early diagnosis of SpA.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 20007287     DOI: 10.1093/rheumatology/kep379

Source DB:  PubMed          Journal:  Rheumatology (Oxford)        ISSN: 1462-0324            Impact factor:   7.580


  13 in total

1.  Parameters related to a positive test result for FDG PET(/CT) for large vessel vasculitis: a multicenter retrospective study.

Authors:  G A Hooisma; H Balink; P M Houtman; R H J A Slart; K D F Lensen
Journal:  Clin Rheumatol       Date:  2012-02-10       Impact factor: 2.980

2.  Systemic and vascular inflammation in patients with moderate to severe psoriasis as measured by [18F]-fluorodeoxyglucose positron emission tomography-computed tomography (FDG-PET/CT): a pilot study.

Authors:  Nehal N Mehta; YiDing Yu; Babak Saboury; Negar Foroughi; Parasuram Krishnamoorthy; Anna Raper; Amanda Baer; Jules Antigua; Abby S Van Voorhees; Drew A Torigian; Abass Alavi; Joel M Gelfand
Journal:  Arch Dermatol       Date:  2011-05-16

3.  18F-FDG PET/CT for identifying the potential causes and extent of secondary hemophagocytic lymphohistiocytosis.

Authors:  Leilei Yuan; Ying Kan; Jacqui K Meeks; Daqing Ma; Jigang Yang
Journal:  Diagn Interv Radiol       Date:  2016 Sep-Oct       Impact factor: 2.630

Review 4.  Entheseal involvement in systemic disorders.

Authors:  Gleb Slobodin; Doron Rimar; Nina Boulman; Lisa Kaly; Michael Rozenbaum; Itzhak Rosner; Majed Odeh
Journal:  Clin Rheumatol       Date:  2015-09-10       Impact factor: 2.980

5.  Assessment of (18)F-fluorodeoxyglucose positron emission tomography combined with computed tomography in the preoperative management of patients with gastric cancer.

Authors:  Tsutomu Namikawa; Takehiro Okabayshi; Munenobu Nogami; Yasuhiro Ogawa; Michiya Kobayashi; Kazuhiro Hanazaki
Journal:  Int J Clin Oncol       Date:  2013-07-24       Impact factor: 3.402

6.  Correlation of benign incidental findings seen on whole-body PET-CT with knee MRI: patterns of 18F-FDG avidity, intra-articular pathology, and bone marrow edema lesions.

Authors:  Christopher J Burke; William R Walter; Sushma Gaddam; Hien Pham; James S Babb; Joseph Sanger; Fabio Ponzo
Journal:  Skeletal Radiol       Date:  2018-06-21       Impact factor: 2.199

Review 7.  The role of 18F-FDG PET/CT in large-vessel vasculitis: appropriateness of current classification criteria?

Authors:  H Balink; R J Bennink; B L F van Eck-Smit; H J Verberne
Journal:  Biomed Res Int       Date:  2014-08-14       Impact factor: 3.411

Review 8.  Clinical value of whole-body PET/CT in patients with active rheumatic diseases.

Authors:  Hiroyuki Yamashita; Kazuo Kubota; Akio Mimori
Journal:  Arthritis Res Ther       Date:  2014       Impact factor: 5.156

Review 9.  Radionuclide Methods in the Diagnosis of Sacroiliitis in Patients with Spondyloarthritis: An Update.

Authors:  Karina Zilber; Miguel Gorenberg; Doron Rimar; Nina Boulman; Lisa Kaly; Michael Rozenbaum; Itzhak Rosner; Gleb Slobodin
Journal:  Rambam Maimonides Med J       Date:  2016-10-31

10.  Diagnostic value of 18F-fluorodeoxyglucose uptake parameters to differentiate rheumatoid arthritis from other types of arthritis.

Authors:  Anu Bhattarai; Takahito Nakajima; Santosh Sapkota; Yukiko Arisaka; Azusa Tokue; Yukio Yonemoto; Yoshito Tsushima
Journal:  Medicine (Baltimore)       Date:  2017-06       Impact factor: 1.889

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.